Non‐Targeting shRNA‐Encoded Plasmid DNA Enhances Protective Immunity Through RIDD‐RIG‐I Signaling Pathway in the Zika Virus Animal Model
Advanced Science · 2026
DOI: 10.1002/advs.202517420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Min-Syuan Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Miaoli, Taiwan. Hauptthemen laut MEDLINE: Vaccines, DNA, Zika Virus Infection, RNA, Small Interfering, Zika Virus. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, National Health Research Institutes.
Abstract (Originalsprache)
DNA vaccines offer advantages such as low production cost, rapid manufacturing, and enhanced stability for transport and storage, making them suitable for addressing tropical and emerging infectious diseases. However, their limited immunogenicity in humans often necessitates multiple booster doses or high antigen quantities, posing a significant barrier to broader application. To overcome this limitation, we developed a DNA vaccine encoding the Zika virus (ZIKV) structural proteins (prME) that incorporates a non‐targeting short hairpin RNA (shRNA) as an intrinsic molecular adjuvant. This shRNA is not designed to silence host genes; rather, it enhances innate immune “RIG‐I” signaling by selectively activating the IRE1α‐dependent regulated IRE1‐dependent decay pathway. Mechanistically, shRNA overexpression is inferred to increase the load on the RNA‐induced silencing complex, potentially triggering IRE1α oligomerization and subsequent upregulation of TXNIP. These events generate cytoplasmic RNA fragments that activate RIG‐I and downstream antiviral responses. In murine models, the vaccine elicited strong ZIKV‐specific humoral and cellular immune responses. In AGB6 mice, it significantly increased neutralizing antibody titers, reduced viremia, and improved survival. This approach enhances the immunogenicity of DNA vaccines without targeting host genes, providing a scalable and adaptable platform for infectious disease prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Infectious Disease and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.
- Institute of Biotechnology, College of Life Science and Medicine, National Tsing Hua University, Hsinchu, Taiwan.
- Welgene Biotech. Co., Ltd., Taipei, Taiwan.
- Immunology Research Center, National Health Research Institutes, Miaoli, Taiwan.
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
- Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
ORCID-Profile: Shih-Jen Liu
Förderung
- National Science and Technology Council
- National Health Research Institutes
Zitieren
APA
Huang, M. S., Liao, H. C., Peng, P., Wu, W. L., Chai, K. M., Chen, M. Y., Yu, G. Y., Chuang, T. H., Chen, H. W., Chang, C. R., & Liu, S. J. (2026). Non‐Targeting shRNA‐Encoded Plasmid DNA Enhances Protective Immunity Through RIDD‐RIG‐I Signaling Pathway in the Zika Virus Animal Model. Advanced Science. https://doi.org/10.1002/advs.202517420
Vancouver
Huang MS, Liao HC, Peng P, Wu WL, Chai KM, Chen MY, et al. Non‐Targeting shRNA‐Encoded Plasmid DNA Enhances Protective Immunity Through RIDD‐RIG‐I Signaling Pathway in the Zika Virus Animal Model. Advanced Science. 2026. doi:10.1002/advs.202517420
BibTeX
@article{Huang2026,
author = {Huang, Min-Syuan and Liao, Hung-Chun and Peng, Po and Wu, Wan-Ling and Chai, Kit Man and Chen, Mei-Yu and Yu, Guann-Yi and Chuang, Tsung-Hsien and Chen, Hsin-Wei and Chang, Chuang-Rung and Liu, Shih-Jen},
title = {Non‐Targeting shRNA‐Encoded Plasmid DNA Enhances Protective Immunity Through RIDD‐RIG‐I Signaling Pathway in the Zika Virus Animal Model},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202517420}
}
EUVIMED